Ascend Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-58,266
Closed -$2.48M 215
2017
Q4
$2.48M Sell
58,266
-26,456
-31% -$1.13M 0.09% 164
2017
Q3
$3.64M Buy
+84,722
New +$3.64M 0.14% 117